UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1974, 192 p., [4] leaves of plates
Book
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2107 - 2117
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Age Distribution | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Humans | Middle Aged | Sulfonylurea Compounds - adverse effects | Thiazolidinediones - adverse effects | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Randomized Controlled Trials as Topic | Aged, 80 and over | Observational Studies as Topic | Adult | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Cardiomyopathies - chemically induced | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Heart Failure - chemically induced | Heart failure | Enzyme inhibitors | Cardiac patients | Angiotensin | Diabetes | Glucose | Drug therapy | Dextrose | Diabetes therapy | Hypertension | Diabetic retinopathy | Stroke | Heart attacks | Pathogenesis | Cardiomyopathy | Mortality | Clinical trials | Cardiovascular disease | Studies | Medical prognosis | Index Medicus | Abridged Index Medicus
Journal Article
2013, Advances in cultural psychology : constructing human development, ISBN 1623963168, xi, 462
Book
The Journal of steroid biochemistry and molecular biology, ISSN 0960-0760, 10/2018, Volume 183, pp. 10 - 17
Osteoblast | Alkaline phosphatase | Osteoclast | Raloxifene | Puerarin | Lasofoxifene | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Physiological aspects | Phenols | Phosphatases | Estradiol | Stem cells | Cell proliferation | Osteoprogenitor cells | Cbfa-1 protein | Mesenchyme | Estrogens | Estrogen receptors | Bone turnover | Osteoblasts | Bone resorption | Cell growth | Bone growth | Bones | Ligands | Osteoclasts | Selective estrogen receptor modulators | Osteogenesis | puerarin | alkaline phosphatase | osteoblast | raloxifene | osteoclast | lasofoxifene | bone-marrow | postmenopausal women | gene | breast-cancer | osteoporosis | androgen receptor | deficiency | Biokemi och molekylärbiologi | osteoblast differentiation | cbfa1 | alpha | Biochemistry and Molecular Biology
Journal Article
Brazilian journal of biology, ISSN 1519-6984, 02/2016, Volume 76, Issue 1, p. 59
Journal Article
Medical science educator, ISSN 2156-8650, 3/2018, Volume 28, Issue 1, pp. 101 - 110
Journal Article
1998, Electronic packaging and interconnection series, ISBN 0070266999, 1 v. (various pagings)
Book
Clinical genetics, ISSN 0009-9163, 08/2016, Volume 90, Issue 2, pp. 134 - 140
minimal prevalence | segregation distortion | SCA3 | spinocerebellar ataxia type 3 | MJD | CAG expansion transmission | Machado–Joseph disease | CAG expansion instabilities | Machado-Joseph disease | Minimal prevalence | Segregation distortion | Spinocerebellar ataxia type 3 | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Severity of Illness Index | Genomic Instability | Chromosome Segregation | Age Factors | Gene Frequency | Humans | Repressor Proteins - genetics | Male | Meiosis | Asymptomatic Diseases | Trinucleotide Repeat Expansion | Inheritance Patterns | Pedigree | Adolescent | Age of Onset | Alleles | Sex Factors | Adult | Female | Heterozygote | Ataxin-3 - genetics | Machado-Joseph Disease - genetics | Machado-Joseph Disease - pathology | Siblings | Epidemiology | Spinocerebellar ataxia | Disease transmission | Cell division | Ataxia | Genetic disorders | Population genetics | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2006, Volume 368, Issue 9549, pp. 1771 - 1781
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sulfones - therapeutic use | Diclofenac - therapeutic use | Diclofenac - adverse effects | Humans | Middle Aged | Sulfones - adverse effects | Male | Osteoarthritis - drug therapy | Randomized Controlled Trials as Topic | Cyclooxygenase 2 Inhibitors - adverse effects | Pyridines - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Multicenter Studies as Topic | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Female | Aged | Cardiovascular Diseases - chemically induced | Pyridines - therapeutic use | Etoricoxib | Patient outcomes | Rheumatoid arthritis | Cardiovascular diseases | Drug therapy | Health aspects | Osteoarthritis | Diclofenac | Complications and side effects | Dosage and administration | Risk factors | Studies | Design | Regulatory agencies | Clinical trials | Cardiovascular disease | Informed consent | Pharmaceutical industry | Long term | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2003, Volume 362, Issue 9378, pp. 147 - 158
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Heart Failure - therapy | Age Factors | Comorbidity | Humans | Sex Factors | Female | Male | Heart Failure - epidemiology | Disease Progression | Heart failure | Causes of | Demographic aspects | Prevention | Complications and side effects | Care and treatment | Chronic diseases | Risk factors | Demographics | Medical disorders | Public health | Hypertension | Demography | Decision making | Mortality | Diabetes mellitus | Disorders | Clinical trials | Beta blockers | Epidemiology | Coronary artery disease | Subgroups | Quality of life | Health risk assessment | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article